Invitrogen, Genetic Applications Settle Lawsuit
 
Invitrogen and Genetic Applications have settled a lawsuit that Genetic Applications filed last year alleging Invitrogen’s infringement of a patent covering gene-transfer technology.
 
According to court documents, the US District Court for the Eastern District of Texas dismissed the case on Dec. 10 in response to a request from Genetic Applications. Terms of the settlement were not disclosed, and Invitrogen officials declined to comment further.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.